Home
About
Overview
Sharing Data
ORCID
Help
History (21)
Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant.
Propensity-score adjusted comparison of pathologic nodal upstaging by robotic, video-assisted thoracoscopic, and open lobectomy for non-small cell lung cancer.
The "Treat to Target" Approach to Rheumatoid Arthritis.
Galectin 3 and incident atrial fibrillation in the community.
Mutational fitness landscape and drug resistance.
See All 21 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Mutational fitness landscape and drug resistance.
Flynn J, Samant N, Schneider-Nachum G, Tenzin T, Bolon DNA. Mutational fitness landscape and drug resistance. Curr Opin Struct Biol. 2023 02; 78:102525.
View in:
PubMed
subject areas
Drug Resistance
Genetic Fitness
Models, Genetic
Mutation
Proteins
authors with profiles
Daniel N Bolon PhD